Hepatitis B Virus Antigen Peptides/Hepatitis G2 Cell Protein Lysate-activated Dendritic
Cells - CISMeF
Hepatitis B Virus Antigen Peptides/Hepatitis G2 Cell Protein Lysate-activated Dendritic
CellsNCIt concept
Preferred Label : Hepatitis B Virus Antigen Peptides/Hepatitis G2 Cell Protein Lysate-activated Dendritic
Cells;
NCIt synonyms : HBV Antigen Peptides/HepG2 Cell Protein Lysate-activated Dendritic Cells; HBV Antigen Peptides/HepG2 Cell Protein Lysate-activated DCs;
NCIt definition : A cell-based cancer vaccine composed of autologous dendritic cells (DCs) ex vivo activated
with the hepatitis B virus (HBV)-specific tumor-associated antigen (TAA) peptides
derived from the patient's tumor and cell lysate proteins harvested from the immortalized
human liver cancer cell line HepG2, with potential immunostimulatory and antineoplastic
activities. Upon administration, the HBV peptides/HepG2 cell protein lysate-activated
DCs expose the immune system to the HBV epitopes and an undefined amount of other
TAAs from the HepG2 cell lysate, which may result in the induction of a specific anti-tumor
cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing
the HBV/HepG2 TAAs. HBV TAAs are found on HBV-positive cells and on HBV-induced hepatocellular
carcinoma (HBV-HCC).;